Were currently exploring this within CalorieScience and would genuinely value perspectives from dietitians, nutritionists, obesity specialists, endocrinologists, and researchers
Switching from retatrutide to tirzepatide This direction is simpler because you are removing a receptor pathway rather than adding one: Stop retatrutide and allow 1-2 weeks washout Start tirzepatide at 2.5 mg per standard protocol Escalate normally every 4 weeks Expect potentially faster tolerance since your GLP-1 and GIP receptors already have exposure history Some researchers report smoother GI tolerance when switching from a triple to a dual agonist, which makes pharmacological sense
Metabolic Benefits: The metabolic improvements from semaglutide GLP-1 include: Improved Insulin Sensitivity: By delaying gastric emptying, semaglutide GLP-1 allows for slower nutrient absorption, enhancing insulin sensitivity and aiding in blood sugar control
Louis, MO), (VPA-exposed group), while control animals received an equivalent volume of saline (SAL) adjusted according to body weight (0.09% NaCl) via i.p., (SAL-exposed group)